Erin E. Kershaw, MD

NPI 1346228228ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Pittsburgh, PA

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Pittsburgh, Pennsylvania, trained at Js Weill Medical College, Cornell University (class of 1997). Their prescriptions cost Medicare Part D more than their services did: $121,591 for 409 claims, against $2,980 paid for services in 2024. Novo Nordisk Inc was the largest of 4 companies reporting payments in 2025, $3,775 in all, mostly consulting fees.

Overview

NPI	1346228228
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jan 2, 2006
Last updated in NPPES	Nov 16, 2022
Certified by provider	Nov 16, 2022

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	MD435015	PA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (PA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	15
Services billed	43 across 3 procedure codes
Paid by Medicare	$2,980

Part D prescriptions in 2024

Prescriptions (claims)	409 · 999 30-day fills
Patients	51
Total drug cost	$121,591
Generic share	67% of claims

Medicare sources and data years

Education and affiliations

Medical school	Js Weill Medical College, Cornell University
Graduation year	1997
Medicare specialty	Endocrinology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth